Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Editor's Blog and Industry Comments

German research focuses on light-activated reversal of anaesthesia

14 September, 2012
A new study at Ludwig-Maximilians-Universitaet Muenchen (LMU) has discoverd that a light-sensitive moiety can been added to propofol, a commonly used anaesthetic, allowing its narcotic effect to be controlled by light.


The compound also offers a possible route to the treatment of certain eye diseases.



Inhibitory neurotransmitters dampen the activity of neurons. The regulatory effect forms the basis for the action of many anaesthetics. For example, propofol, a common anaesthetic, interacts with receptors on neural cell membranes that normally bind the inhibitory neurotransmitter gammaaamino butyric acid (GABA). Binding of GABA opens protein channels through which negatively charged chloride ions stream into the cell. By raising the resting electrical potential across the membrane, this makes the cell less likely to fire in response to an incoming stimulus. Propofol magnifies this effect and this functions as an anaesthetic.



Dirk Trauner, Professor of Chemical Biology and Genetics at LMU and a member of the Excellence Cluster CIPSM, is a specialist in the art of conferring on 'blind' nerve cells the ability to react to light. Working with colleagues based in Switzerland and the US, he has now developed a derivative of propofol that allows the action of the GABA receptor to be regulated by light. "By attaching a molecular switch to propofol, we have obtained a light-sensitive molecule that is a more potent anaesthetic than propofol itself, in the dark," Trauner explained.



In this case, light serves to largely inactivate the anaesthetic effect of the compound, as the researchers were able to demonstrate in experiments on tadpoles. When exposed to a low concentration of the propofol derivative, the animals were anesthetized, as expected. However, when irradiated with violet light, they promptly revived, but remained active only as long as the light was on. In the dark, they were immobilized once again. The lightedependent effect is completely reversible, as the tadpoles recovered fully upon transfer to their normal aquarium.



The new agent could be used to treat certain forms of blindness, such as retinitis pigmentosa, which leads to loss of vision owing to progressive destruction of photoreceptors. However, neurons deeper in the retina are unaffected, and are accessible to ambient light. "The inner cells also bear GABA receptors on their surfaces, and in principle they could be turned into light-responsive cells with the help of the new compound, which would allow us to bypass the defective photoreceptors," said Trauner.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo